{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:55:38Z","timestamp":1773114938054,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,29]]},"DOI":"10.7759\/cureus.53188","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T01:44:00Z","timestamp":1706579040000},"source":"Crossref","is-referenced-by-count":1,"title":["Rice Bran Arabinoxylan Compound and Quality of Life (RBAC-QoL) of Cancer Patients: An Interim Analysis of the RBAC-QoL Study"],"prefix":"10.7759","author":[{"given":"Soo Liang","family":"Ooi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S","family":"Micalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sok Cheon","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1534735417735379","article-title":"Evidence-based review of BioBran\/MGN-3 arabinoxylan compound as a complementary therapy for conventional cancer treatment","volume":"17","author":"Ooi SL","year":"2018","unstructured":"Ooi SL, McMullen D, Golombick T, Nut D, Pak SC. Evidence-based review of BioBran\/MGN-3 arabinoxylan compound as a complementary therapy for conventional cancer treatment. Integr Cancer Ther. 2018, 17:165-78. 10.1177\/1534735417735379","journal-title":"Integr Cancer Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28176313","article-title":"Modified rice bran arabinoxylan by Lentinus edodes mycelial enzyme as an immunoceutical for health and aging - a comprehensive literature review","volume":"28","author":"Ooi SL","year":"2023","unstructured":"Ooi SL, Micalos PS, Pak SC. Modified rice bran arabinoxylan by Lentinus edodes mycelial enzyme as an immunoceutical for health and aging - a comprehensive literature review. Molecules. 2023, 28:6313. 10.3390\/molecules28176313","journal-title":"Molecules"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202310.1057.v1","article-title":"Rice bran arabinoxylan compound as a natural product for cancer treatment - an evidence-based assessment of the effects and mechanisms.","author":"Ooi SL","year":"2023","unstructured":"Ooi SL, Micalos PS, Kim J, Pak SC. Rice bran arabinoxylan compound as a natural product for cancer treatment - an evidence-based assessment of the effects and mechanisms.. Preprints.org. 2023, 202310. 10.20944\/preprints202310.1057.v1","journal-title":"Preprints.org"},{"key":"ref4","article-title":"The immunomodulating effects of arabinoxylan rice bran (Lentin) on hematologic profile, nutritional status and quality of life among head and neck carcinoma patients undergoing radiation therapy: a double blind randomized control trial","volume":"12","author":"Tan DF","year":"2020","unstructured":"Tan DF, Flores JA. The immunomodulating effects of arabinoxylan rice bran (Lentin) on hematologic profile, nutritional status and quality of life among head and neck carcinoma patients undergoing radiation therapy: a double blind randomized control trial. Radiology Journal. 2020, 12:11-16.","journal-title":"Radiology Journal"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100580","article-title":"Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial","volume":"19","author":"Ooi SL","year":"2020","unstructured":"Ooi SL, Pak SC, Micalos PS, et al.. Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial. Contemp Clin Trials Commun. 2020, 19:100580. 10.1016\/j.conctc.2020.100580","journal-title":"Contemp Clin Trials Commun"},{"key":"ref6","article-title":"The EORTC QLQ-C30 Scoring Manual (3rd Edition)","author":"Fayers PM","year":"2001","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 Scoring Manual (3rd Edition). European Organisation for Research and Treatment of Cancer, Brussels; 2001."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.0107","article-title":"Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","volume":"29","author":"Cocks K","year":"2011","unstructured":"Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011, 29:89-96. 10.1200\/JCO.2010.28.0107","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/nu7020785","article-title":"The comparative validity and reproducibility of a diet quality index for adults: the Australian Recommended Food Score","volume":"7","author":"Collins CE","year":"2015","unstructured":"Collins CE, Burrows TL, Rollo ME, et al.. The comparative validity and reproducibility of a diet quality index for adults: the Australian Recommended Food Score. Nutrients. 2015, 7:785-98. 10.3390\/nu7020785","journal-title":"Nutrients"},{"key":"ref9","unstructured":"Trinity College Dublin. Scoring the International Physical Activity Questionnaire (IPAQ). (2018). Accessed. January 28, 2024: https:\/\/ugc.futurelearn.com\/uploads\/files\/bc\/c5\/bcc53b14-ec1e-4d90-88e3-1568682f32ae\/IPAQ_PDF.pdf."},{"key":"ref10","unstructured":"Milliplex MAP human cytokine\/chemokine magnetic bead panel II - premixed 23 plex - immunology multiplex assay. (2024). Accessed. January 28, 2024: https:\/\/www.merckmillipore.com\/SG\/en\/product\/MILLIPLEX-MAP-Human-Cytokine-Chemokine-Magnetic-Bead-Panel-II-Premixed-2...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen E","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, et al.. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019, 37:852-7. 10.1038\/s41587-019-0209-9","journal-title":"Nat Biotechnol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1590\/2176-9451.20.3.013-015.ebo","article-title":"CONSORT: when and how to use it","volume":"20","author":"Falci SG","year":"2015","unstructured":"Falci SG, Marques LS. CONSORT: when and how to use it. Dental Press J Orthod. 2015, 20:13-5. 10.1590\/2176-9451.20.3.013-015.ebo","journal-title":"Dental Press J Orthod"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4868-6","article-title":"Patients' quality of life during active cancer treatment: a qualitative study","volume":"18","author":"Sibeoni J","year":"2018","unstructured":"Sibeoni J, Picard C, Orri M, Labey M, Bousquet G, Verneuil L, Revah-Levy A. Patients' quality of life during active cancer treatment: a qualitative study. BMC Cancer. 2018, 18:951. 10.1186\/s12885-018-4868-6","journal-title":"BMC Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/2347-5625.204499","article-title":"Quality of life and its determinants in adult cancer patients undergoing chemotherapy treatment in Pakistan","volume":"4","author":"Chagani P","year":"2017","unstructured":"Chagani P, Parpio Y, Gul R, Jabbar AA. Quality of life and its determinants in adult cancer patients undergoing chemotherapy treatment in Pakistan. Asia Pac J Oncol Nurs. 2017, 4:140-6. 10.4103\/2347-5625.204499","journal-title":"Asia Pac J Oncol Nurs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens D","year":"2013","unstructured":"Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013, 4:863. 10.3389\/fpsyg.2013.00863","journal-title":"Front Psychol"},{"key":"ref16","article-title":"\u201cBIOBRAN MGN-3\"; Effect of reducing side effects of chemotherapy in breast cancer patients","volume":"20","author":"Masood AI","year":"2013","unstructured":"Masood AI, Sheikh R, Anwer RA. \u201cBIOBRAN MGN-3\"; Effect of reducing side effects of chemotherapy in breast cancer patients. Professional Med J. 2013, 20:13-16.","journal-title":"Professional Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eujim.2016.10.004","article-title":"Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3Arabinoxylane) and targeted radiofrequency heat therapy","volume":"8","author":"Petrovics G","year":"2016","unstructured":"Petrovics G, Szigeti G, Hamvas S, Mate A, Betlehem J, Hegyi G. Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3Arabinoxylane) and targeted radiofrequency heat therapy. Eur J Integr Med. 2016, 8:29-35. 10.1016\/j.eujim.2016.10.004","journal-title":"Eur J Integr Med"},{"key":"ref18","article-title":"Response interpolation and scale sensitivity: evidence against 5-point scales","volume":"5","author":"Finstad K","year":"2010","unstructured":"Finstad K. Response interpolation and scale sensitivity: evidence against 5-point scales. J Usability Stud. 2010, 5:104-110.","journal-title":"J Usability Stud"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.4720","article-title":"Self-evaluation of adjuvant chemotherapy-related adverse effects by patients with breast cancer","volume":"2","author":"Montemurro F","year":"2016","unstructured":"Montemurro F, Mittica G, Cagnazzo C, et al.. Self-evaluation of adjuvant chemotherapy-related adverse effects by patients with breast cancer. JAMA Oncol. 2016, 2:445-52. 10.1001\/jamaoncol.2015.4720","journal-title":"JAMA Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/974390","article-title":"A randomized, double-blind pilot trial of hydrolyzed rice bran versus placebo for radioprotective effect on acute gastroenteritis secondary to chemoradiotherapy in patients with cervical cancer","volume":"2015","author":"Itoh Y","year":"2015","unstructured":"Itoh Y, Mizuno M, Ikeda M, et al.. A randomized, double-blind pilot trial of hydrolyzed rice bran versus placebo for radioprotective effect on acute gastroenteritis secondary to chemoradiotherapy in patients with cervical cancer. Evid Based Complement Alternat Med. 2015, 2015:974390. 10.1155\/2015\/974390","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/1534735416635742","article-title":"Addition of rice bran arabinoxylan to curcumin therapy may be of benefit to patients with early-stage B-cell lymphoid malignancies (monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0\/1 chronic lymphocytic leukemia): a preliminary clinical study","volume":"15","author":"Golombick T","year":"2016","unstructured":"Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Addition of rice bran arabinoxylan to curcumin therapy may be of benefit to patients with early-stage B-cell lymphoid malignancies (monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0\/1 chronic lymphocytic leukemia): a preliminary clinical study. Integr Cancer Ther. 2016, 15:183-9. 10.1177\/1534735416635742","journal-title":"Integr Cancer Ther"},{"key":"ref22","article-title":"Effect of long-term administration of immunomodulatory food on cancer patients completing conventional treatments","volume":"14","author":"Tsunekawa H","year":"2004","unstructured":"Tsunekawa H. Effect of long-term administration of immunomodulatory food on cancer patients completing conventional treatments. Clinical Pharmacology and Therapy. 2004, 14:295-302.","journal-title":"Clinical Pharmacology and Therapy"},{"key":"ref23","article-title":"Management of neutropenia in cancer patients","volume":"10","author":"Lustberg MB","year":"2012","unstructured":"Lustberg MB. Management of neutropenia in cancer patients. Clin Adv Hematol Oncol. 2012, 10:825-6.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref24","article-title":"Serum total protein, albumin and A\/G ratio in different grades of protein energy malnutrition","volume":"14","author":"Rahman MZ","year":"2005","unstructured":"Rahman MZ, Begum BA. Serum total protein, albumin and A\/G ratio in different grades of protein energy malnutrition. Mymensingh Med J. 2005, 14:38-40.","journal-title":"Mymensingh Med J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s40795-023-00694-0","article-title":"Blood biomarkers as potential malnutrition screening alternatives among adult patients with cancer on treatment in oncology unit of jimma tertiary hospital: A cross-sectional analysis","volume":"9","author":"Enkobahry A","year":"2023","unstructured":"Enkobahry A, Sime T, Kene K, Mateos T, Dilnesa S, Zawdie B. Blood biomarkers as potential malnutrition screening alternatives among adult patients with cancer on treatment in oncology unit of jimma tertiary hospital: A cross-sectional analysis. BMC Nutr. 2023, 9:38. 10.1186\/s40795-023-00694-0","journal-title":"BMC Nutr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19116881","article-title":"Nutritional treatment of patients with colorectal cancer","volume":"19","author":"Lewandowska A","year":"2022","unstructured":"Lewandowska A, Religioni U, Czerw A, et al.. Nutritional treatment of patients with colorectal cancer. Int J Environ Res Public Health. 2022, 19:6881. 10.3390\/ijerph19116881","journal-title":"Int J Environ Res Public Health"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174154","article-title":"Physical activity and cancer care - a review","volume":"14","author":"Misi\u0105g W","year":"2022","unstructured":"Misi\u0105g W, Piszczyk A, Szyma\u0144ska-Chabowska A, Chabowski M. Physical activity and cancer care - a review. Cancers (Basel). 2022, 14:4154. 10.3390\/cancers14174154","journal-title":"Cancers (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4230-1","article-title":"Knowledge, attitudes, and practice of oncologists and oncology health care providers in promoting physical activity to cancer survivors: an international survey","volume":"26","author":"Hardcastle SJ","year":"2018","unstructured":"Hardcastle SJ, Kane R, Chivers P, Hince D, Dean A, Higgs D, Cohen PA. Knowledge, attitudes, and practice of oncologists and oncology health care providers in promoting physical activity to cancer survivors: an international survey. Support Care Cancer. 2018, 26:3711-9. 10.1007\/s00520-018-4230-1","journal-title":"Support Care Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00136408","article-title":"Small studies: strengths and limitations","volume":"32","author":"Hackshaw A","year":"2008","unstructured":"Hackshaw A. Small studies: strengths and limitations. Eur Respir J. 2008, 32:1141-3. 10.1183\/09031936.00136408","journal-title":"Eur Respir J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/201608-rice-bran-arabinoxylan-compound-and-quality-of-life-rbac-qol-of-cancer-patients-an-interim-analysis-of-the-rbac-qol-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:42Z","timestamp":1707509682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/201608-rice-bran-arabinoxylan-compound-and-quality-of-life-rbac-qol-of-cancer-patients-an-interim-analysis-of-the-rbac-qol-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.53188","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}